LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Halozyme Therapeutics
HALO
YETI Holdings
YETI
DexCom
DXCM
(Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 11.76%34.18B | 35.36%118.55B | 29.28%37.2B | 30.59%31.92B | 68.74%18.85B | 31.83%30.58B | -1.63%87.58B | 16.81%28.77B | -3.72%24.44B | -22.84%11.17B |
Net income from continuing operations | 10.66%24.67B | 21.80%88.14B | 9.74%22.04B | 19.89%21.94B | 33.15%21.87B | 26.97%22.29B | -0.52%72.36B | 19.96%20.08B | 9.39%18.3B | -12.47%16.43B |
Operating gains losses | -992.86%-125M | 55.61%305M | 0.00%44M | 222.50%49M | -7.48%198M | 163.64%14M | 147.92%196M | -71.97%44M | -138.10%-40M | 169.71%214M |
Depreciation and amortization | 88.29%7.38B | 60.79%22.29B | 64.69%6.38B | 69.82%6.03B | 63.35%5.96B | 40.54%3.92B | -4.14%13.86B | -2.64%3.87B | -5.94%3.55B | 4.35%3.65B |
Deferred tax | -152.29%-1.43B | 21.80%-4.74B | 39.35%-1.15B | 21.01%-1.32B | -30.42%-1.7B | 52.31%-568M | -6.26%-6.06B | -767.14%-1.89B | -745.96%-1.68B | -813.11%-1.31B |
Change In working capital | -64.60%856M | 176.38%1.82B | 69.31%7.18B | 36.84%2.52B | 0.45%-10.3B | 29.10%2.42B | -635.43%-2.39B | 188.05%4.24B | -40.01%1.84B | -8.30%-10.35B |
-Change in receivables | 27.22%14.04B | -75.95%-7.19B | -17.81%-13.25B | -44.03%-2.03B | 6.73%-2.95B | -5.93%11.03B | 40.20%-4.09B | 11.00%-11.24B | -264.29%-1.41B | 42.92%-3.16B |
-Change in inventory | 26.14%-373M | 3.38%1.28B | -85.29%55M | 145.28%260M | 12.95%1.47B | 7.00%-505M | 210.60%1.24B | 181.13%374M | 137.99%106M | 231.22%1.31B |
-Change in payables and accrued expense | -175.45%-916M | 269.93%5.23B | 518.15%5.89B | 259.21%648M | -22.50%-2.52B | 177.47%1.21B | -204.62%-3.08B | -64.16%953M | -178.27%-407M | -975.74%-2.06B |
-Change in other current assets | 34.39%-1.84B | -75.48%-8.47B | 5.02%-3.77B | -298.33%-1.19B | -53.61%-702M | -181.46%-2.81B | -37.28%-4.82B | -26.14%-3.97B | 194.47%598M | -485.90%-457M |
-Change in other current liabilities | -44.48%-5.51B | 98.80%5.62B | 77.65%5.09B | 65.66%2.85B | -28.13%1.49B | 0.55%-3.82B | -10.86%2.83B | -18.15%2.86B | -0.23%1.72B | 12.95%2.08B |
-Change in other working capital | -67.97%-4.54B | -3.38%5.35B | -13.75%13.16B | 60.34%1.98B | 11.89%-7.09B | 7.25%-2.7B | -4.65%5.54B | 32.09%15.26B | 39.80%1.23B | -25.77%-8.05B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 11.76%34.18B | 35.36%118.55B | 29.28%37.2B | 30.59%31.92B | 68.74%18.85B | 31.83%30.58B | -1.63%87.58B | 16.81%28.77B | -3.72%24.44B | -22.84%11.17B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -3,122.07%-15.2B | -327.56%-96.97B | -62.56%-14.85B | -227.82%-10.7B | -905.94%-71.93B | 116.06%503M | 25.18%-22.68B | 6.12%-9.13B | 79.82%-3.26B | -515.85%-7.15B |
Net PPE purchase and sale | -50.48%-14.92B | -58.24%-44.48B | -55.13%-13.87B | -65.76%-10.95B | -55.16%-9.74B | -57.84%-9.92B | -17.67%-28.11B | -30.16%-8.94B | -23.73%-6.61B | -6.97%-6.27B |
Net business purchase and sale | -55.90%-1.85B | -4,039.64%-69.13B | -293.55%-1.34B | -423.26%-1.58B | -9,477.17%-65.03B | -239.83%-1.19B | 92.42%-1.67B | 73.00%-341M | 98.39%-301M | 20.12%-679M |
Net investment purchase and sale | -80.27%2.48B | 75.63%17.94B | 78.76%749M | -41.69%3.11B | 1,334.62%1.49B | 188.72%12.59B | -44.61%10.21B | 191.68%419M | -41.23%5.33B | -98.16%104M |
Net other investing changes | 7.03%-913M | 58.34%-1.3B | -42.01%-382M | 24.02%-1.28B | 547.51%1.35B | -14.19%-982M | -10.30%-3.12B | 76.36%-269M | -42.76%-1.69B | -238.20%-301M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -3,122.07%-15.2B | -327.56%-96.97B | -62.56%-14.85B | -227.82%-10.7B | -905.94%-71.93B | 116.06%503M | 25.18%-22.68B | 6.12%-9.13B | 79.82%-3.26B | -515.85%-7.15B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -212.30%-16.58B | 14.06%-37.76B | -106.46%-23.56B | -82.78%-18.81B | 10.59%-10.15B | 235.63%14.76B | 25.38%-43.94B | 13.99%-11.41B | 40.67%-10.29B | 5.31%-11.35B |
Net issuance payments of debt | -127.66%-6.71B | 120.91%575M | -1,301.00%-14.01B | ---9.05B | 15.60%-633M | 2,526.50%24.27B | 69.52%-2.75B | ---1B | --0 | ---750M |
Net common stock issuance | 17.97%-3.4B | 25.16%-15.25B | 29.20%-3.68B | 25.78%-3.69B | 28.32%-3.74B | 17.05%-4.15B | 33.95%-20.38B | 37.42%-5.19B | 40.41%-4.97B | 26.97%-5.22B |
Cash dividends paid | -10.35%-5.57B | -9.95%-21.77B | -10.29%-5.57B | -10.14%-5.57B | -10.03%-5.57B | -9.31%-5.05B | -9.18%-19.8B | -9.11%-5.05B | -8.91%-5.06B | -8.90%-5.07B |
Net other financing activities | -189.58%-889M | -30.12%-1.31B | -81.44%-303M | -93.02%-498M | 36.59%-201M | -16.29%-307M | -16.57%-1.01B | 51.03%-167M | -63.29%-258M | -65.10%-317M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -212.30%-16.58B | 14.06%-37.76B | -106.46%-23.56B | -82.78%-18.81B | 10.59%-10.15B | 235.63%14.76B | 25.38%-43.94B | 13.99%-11.41B | 40.67%-10.29B | 5.31%-11.35B |
Net cash flow | ||||||||||
Beginning cash position | -47.23%18.32B | 149.11%34.7B | -26.08%19.63B | 10.60%17.31B | 251.56%80.45B | 149.11%34.7B | -2.06%13.93B | 112.53%26.56B | -24.06%15.65B | 19.41%22.88B |
Current changes in cash | -94.76%2.4B | -177.16%-16.18B | -114.79%-1.22B | -77.87%2.41B | -762.94%-63.22B | 399.26%45.85B | 13,894.08%20.97B | 404.17%8.22B | 233.91%10.89B | -649.59%-7.33B |
Effect of exchange rate changes | 223.23%122M | -8.25%-210M | -27.16%-103M | -375.86%-80M | -18.18%72M | 56.96%-99M | -37.59%-194M | 59.09%-81M | 20.83%29M | -16.98%88M |
End cash Position | -74.10%20.84B | -47.23%18.32B | -47.23%18.32B | -26.08%19.63B | 10.60%17.31B | 251.56%80.45B | 149.11%34.7B | 149.11%34.7B | 112.53%26.56B | -24.06%15.65B |
Free cash flow | -6.82%19.26B | 24.54%74.07B | 17.63%23.32B | 17.56%20.97B | 86.12%9.12B | 22.18%20.67B | -8.71%59.48B | 11.65%19.83B | -11.03%17.83B | -43.13%4.9B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |